logo

For the Inventor, By the Inventor

Brooklyn Park, MN, United States of America

Cima Labs Inc.


USPTO Granted Patents = 41



Trademarks = 5

Forward Citations = 2,393

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Rajendra K Khankari (15 out of 19 patents)

silverMedal John Hontz (15 out of 19 patents)

bronzeMedal S Indiran Pather (10 out of 11 patents)

4.  Joseph R Robinson (9 out of 28 patents)

5.  Jonathan D Eichman (9 out of 14 patents)

6.  Manuel A Vega Zepeda (8 out of 14 patents)

7.  Derek V Moe (8 out of 19 patents)

8.  Walid A Habib (7 out of 7 patents)

9.  Sangeeta V Gupte (7 out of 7 patents)

10.  Ehab Hamed (6 out of 6 patents)

11.  Fred Wehling (5 out of 15 patents)

12.  Steve Schuehle (5 out of 5 patents)

13.  Dinesh K Haswani (4 out of 10 patents)

14.  Victoria Ann O'Neill (4 out of 19 patents)

15.  Navayanarao Madamala (4 out of 4 patents)


Core Competencies:
Abuse Deterrent Formulations
Effervescent Drug Delivery
Oral Dosage Forms
Sublingual Buccal Delivery
Child Resistant Packaging
Taste Masking Systems
Rapidly Dissolving Dosage Forms
Microemulsions
Pediatric Formulations
Granulated Dosage Forms
Pharmaceutical Compositions
Sequential Drug Delivery

41 patents:

1. 10201505 - Immediate release abuse-deterrent granulated dosage forms (2019-02-12),
2. 9974751 - Abuse resistant drug formulation (2018-05-22),
3. 9827204 - Immediate release abuse-deterrent granulated dosage forms (2017-11-28),
4. 9757371 - Immediate release abuse-deterrent granulated dosage forms (2017-09-12),
5. 9707224 - Immediate release abuse-deterrent granulated dosage forms (2017-07-18),
6. 9572803 - Abuse resistant drug formulation (2017-02-21),
7. 9474721 - Abuse-resistant formulations (2016-10-25),
8. 9216176 - Abuse resistant drug formulation (2015-12-22),
9. 8927025 - Alcohol-resistant metoprolol-containing extended-release oral dosage forms (2015-01-06),
10. 8637076 - Prednisolone salt formulations (2014-01-28),
11. 8445018 - Abuse resistant drug formulation (2013-05-21),
12. 8191711 - Bend and peel tablet package (2012-06-05),
13. 7862833 - Effervescent oral opiate dosage forms and methods of administering opiates (2011-01-04),
14. 7862832 - Generally linear effervescent oral fentanyl dosage form and methods of administering (2011-01-04),
15. 7858121 - Effervescent oral fentanyl dosage form and methods of administering fentanyl (2010-12-28),
CIMA LABS INC. is a pharmaceutical company specializing in the development and manufacturing of orally disintegrating tablets (ODTs). With a focus on innovative drug delivery systems, CIMA LABS offers a broad range of proprietary ODT technologies that improve patient compliance and convenience. Their team of experts is dedicated to delivering high-quality and effective pharmaceutical products to enhance patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

41 Patents

#4 in Brooklyn Park, MN

#242 in Minnesota

#8,166 in US

#16,217 in the World

...
Brooklyn Park, MN, United States of America

Cima Labs Inc.

Forward Citations = 2,393

36 inventors:

goldMedal Rajendra K Khankari (15 out of 19 patents)

silverMedal John Hontz (15 out of 19 patents)

bronzeMedal S Indiran Pather (10 out of 11 patents)

4.  Joseph R Robinson (9 out of 28 patents)

5.  Jonathan D Eichman (9 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…